Dashboard
Manage Tickers

AMGNAMGEN INC

Nasdaq amgen.com


$ 324.69 $ 12.19 (3.9 %)    

Thursday, 08-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 449.23 $ 13.30 (3.06 %)
DIA $ 395.05 $ 6.75 (1.74 %)
SPY $ 531.28 $ 11.99 (2.31 %)
TLT $ 95.30 $ -0.59 (-0.62 %)
GLD $ 224.00 $ 3.46 (1.57 %)
$ 324.69
$ 324.68 x 100
-- x --
-- - --
$ 242.81 - $ 346.85
2,707,366
na
175.66B
$ 0.52
$ 56.12
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-14-2024 12-31-2023 10-K
4 10-31-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 04-28-2023 03-31-2023 10-Q
7 02-09-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-16-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-03-2021 06-30-2021 10-Q
14 04-28-2021 03-31-2021 10-Q
15 02-09-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-29-2020 06-30-2020 10-Q
18 05-01-2020 03-31-2020 10-Q
19 02-12-2020 12-31-2019 10-K
20 10-30-2019 09-30-2019 10-Q
21 07-31-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-13-2019 12-31-2018 10-K
24 10-31-2018 09-30-2018 10-Q
25 07-27-2018 06-30-2018 10-Q
26 04-25-2018 03-31-2018 10-Q
27 02-13-2018 12-31-2017 10-K
28 10-26-2017 09-30-2017 10-Q
29 07-26-2017 06-30-2017 10-Q
30 04-27-2017 03-31-2017 10-Q
31 02-14-2017 12-31-2016 10-K
32 10-28-2016 09-30-2016 10-Q
33 07-29-2016 06-30-2016 10-Q
34 05-02-2016 03-31-2016 10-Q
35 02-16-2016 12-31-2015 10-K
36 11-02-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 04-27-2015 03-31-2015 10-Q
39 02-19-2015 12-31-2014 10-K
40 10-29-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

amgen-options-trading-a-deep-dive-into-market-sentiment
Amgen Options Trading: A Deep Dive into Ma...
08/08/2024 14:47:03

td-cowen-maintains-buy-on-amgen-raises-price-target-to-381
TD Cowen Maintains Buy on Amgen, Raises Pr...
08/07/2024 21:11:46

TD Cowen analyst Yaron Weber maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $360 to $381.

amgens-mixed-q2-results-highlight-obesity-drug-potential-analysts-focus-shifts-to-upcoming-clinical-readouts
Amgen's Mixed Q2 Results Highlight Obesity...
08/07/2024 18:01:22

Amgen posted mixed Q2 results. Analysts highlight upcoming clinical readouts in obesity and inflammatory disease as crucial. De...

oppenheimer-maintains-outperform-on-amgen-maintains-380-price-target
Oppenheimer Maintains Outperform on Amgen,...
08/07/2024 17:55:04

Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and maintains $380 price target.

deutsche-bank-reiterates-hold-on-amgen-lowers-price-target-to-305
Deutsche Bank Reiterates Hold on Amgen, Lo...
08/07/2024 17:30:13

Deutsche Bank analyst James Shin reiterates Amgen (NASDAQ:AMGN) with a Hold and lowers the price target from $310 to $305.

b-of-a-securities-maintains-neutral-on-amgen-raises-price-target-to-330
B of A Securities Maintains Neutral on Amg...
08/07/2024 17:08:40

B of A Securities analyst Geoff Meacham maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $325 t...

wall-street-poised-for-second-day-of-gains-while-bank-of-japan-makes-reassurances-dollar-strengthens-against-yen-crude-prices-surge-whats-driving-markets-wednesday
Wall Street Poised For Second Day Of Gains...
08/07/2024 16:46:55

The U.S.

rbc-capital-maintains-outperform-on-amgen-raises-price-target-to-362
RBC Capital Maintains Outperform on Amgen,...
08/07/2024 15:25:41

RBC Capital analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $332 to $...

amgen-faces-near-term-challenges-but-long-term-growth-prospects-remain-strong-analyst
Amgen Faces Near-Term Challenges But Long-...
08/07/2024 14:06:24

Amgen reported a 20% year-over-year increase in second-quarter sales, reaching $8.39 billion, surpassing the $8.33 billion cons...

wells-fargo-downgrades-amgen-to-equal-weight-raises-price-target-to-335
Wells Fargo Downgrades Amgen to Equal-Weig...
08/07/2024 12:54:50

Wells Fargo analyst Mohit Bansal downgrades Amgen (NASDAQ:AMGN) from Overweight to Equal-Weight and raises the price target ...

us-stocks-set-to-extend-gains-despite-mixed-earnings-vix-dips-back-toward-pre-sell-off-levels-analyst-says-pullback-is-a-growth-scare-and-not-calamity
US Stocks Set To Extend Gains Despite Mixe...
08/07/2024 11:45:33

Wall Street could go from strength to strength as the index futures point to another session in the green as investors seek to ...

amgen-sees-fy24-adj-eps-1910-2010-vs-1787-est-total-revenues-328b-338b-vs-303b-est
Amgen Sees FY24 Adj. EPS $19.10-$20.10 vs ...
08/06/2024 20:05:17

amgen-q2-2024-adj-eps-497-misses-501-estimate-sales-8388b-beat-8333b-estimate
Amgen Q2 2024 Adj. EPS $4.97 Misses $5.01 ...
08/06/2024 20:02:03

Amgen (NASDAQ:AMGN) reported quarterly earnings of $4.97 per share which missed the analyst consensus estimate of $5.01 by 0.8 ...

wall-street-rebounds-after-selloff-vix-falls-dollar-surges-against-yen-whats-driving-markets-tuesday
Wall Street Rebounds After Selloff, VIX Fa...
08/06/2024 18:29:26

U.S. stock markets saw a strong recovery on Tuesday, with both the S&P 500 and the Nasdaq 100 climbing over 2%, nearly offs...

amgen-gears-up-for-q2-print-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call
Amgen Gears Up For Q2 Print; These Most Ac...
08/06/2024 15:42:11

us-stocks-set-to-open-higher-after-mondays-crash-vix-plummets-analyst-says-would-have-worried-if-market-surged-higher-without-correction
US Stocks Set To Open Higher After Monday'...
08/06/2024 11:18:59

Strong sell-off may be viewed as an opportunity to load up beaten-down stocks but traders may seek evidence regarding sustainab...

amgens-options-a-look-at-what-the-big-money-is-thinking
Amgen's Options: A Look at What the Big Mo...
08/02/2024 19:48:22

bristol-myers-johnson--johnson-abbvie-astrazeneca-expect-minimal-impact-from-upcoming-medicare-price-negotiations
Bristol Myers, Johnson & Johnson, AbbVie, ...
07/30/2024 18:12:15

Top pharmaceutical companies including Bristol Myers, Johnson & Johnson, AbbVie, and AstraZeneca foresee limited impact fro...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
07/30/2024 17:35:22

100-invested-in-this-stock-20-years-ago-would-be-worth-600-today
$100 Invested In This Stock 20 Years Ago W...
07/30/2024 17:03:27

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION